Kinex Pharmaceuticals Acquires QuaDPharma

Kinex Pharmaceuticals Inc., acquired QuaDPharma, LLC, a Western New York based company specializing in pharmaceutical manufacturing, analytical and support services to the pharmaceutical and biotech industries.

The financial terms of the transaction were not disclosed.

Led by Dr. Johnson Lau, CEO, and Flint Besecker, Chief Business Officer, Kinex is a Buffalo NY, Cranford NJ, Taipei Taiwan and Hong Kong-based specialty oncology pharmaceutical company focused on developing drugs for cancer treatment.

Led by President, Stephen Panaro, Ph.D. QuaDPharma had previously been funded by Rand Capital (NASDAQ: RAND), Advantage Capital Partners and local angel investors.







Join the discussion